Cargando…

Afshinnia F, Rajendiran TM, Karnovsky A, et al. Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort. Kidney Int Rep. 2016;1:256–268

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733677/ https://www.ncbi.nlm.nih.gov/pubmed/29270538 http://dx.doi.org/10.1016/j.ekir.2017.09.002

Ejemplares similares

Karnovsky’s fixative prevents artifacts appearing as vacuolation derived from tissue processing in kidneys treated with antisense oligonucleotide
por: Nishina, Hironobu, et al.
Publicado: (2021)

Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort
por: Afshinnia, Farsad, et al.
Publicado: (2016)

Retraction notice to “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.” Kidney Int Rep. 2021;6:613–623
por: Provenzano, Robert, et al.
Publicado: (2022)

Corrigendum to “Narita I. Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD.” Kidney Int Rep. 2020;5:1383–1384
Publicado: (2021)

SAT-337 Acute kidney injury in patients with solid organ and haematological malignancies: a single centre experience. Kidney Int Rep. 2019;4:S149
Publicado: (2019)

Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637
Publicado: (2018)

Ganesh K, Nair RR, Kurian G, et al. Posterior reversible encephalopathy syndrome in kidney disease. Kidney Int Rep. 2018;3:502–507
Publicado: (2018)

Corrigendum to “Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity” Kidney Int. Rep. 2021;6:1949-1960.
por: Cody, Ellen M., et al.
Publicado: (2021)

Corrigendum to “The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients” [Kidney Int. Rep. 2020 1416–1421]
por: Xu, Xin, et al.
Publicado: (2021)

Corrigendum to “Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries.” Kidney Int Rep. 2020;5:263–277
Publicado: (2020)

Corrigendum to “Kimura T, Snijder R, Nozaki K. Diagnosis patterns of CKD and anemia in the Japanese population.” Kidney Int. Rep. 2020;5:694–705
Publicado: (2020)

Retraction notice to “Roxadustat for CKD Anemia – Starting the Jigsaw Puzzle, What Will the Finished Picture Show?” Kidney Int Rep. 2021;6:559–561
por: Winkelmayer, Wolfgang C., et al.
Publicado: (2022)

Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity
por: Lanzon, Borja, et al.
Publicado: (2021)

Erratum to “Randomized Trial of Acute Changes in Plasma Phosphate After Phosphorus-Standardized Meals in Peritoneal Dialysis” Kidney Int. Rep. 2021;6:304–312
Publicado: (2021)

Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease
por: Liu, Xinhui, et al.
Publicado: (2022)

Corrigendum to “Boudard D, Aureli F, Laurent B, et al. Chronic oral exposure to synthetic amorphous silica (NM-200) results in renal and liver lesions in mice.” Kidney Int Rep. 2019;4:1463–1471
Publicado: (2020)

Corrigendum to “Cataldo E, Cinquantini F, Priola AM, et al. Spontaneous renal artery dissection in Ehler–Danlos syndrome.” Kidney Int Rep. 2019;4:1649–1652
Publicado: (2020)

Erratum to “Perrone RD, Chapman AB, Oberdhan D, et al. The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations.” Kidney Int. Rep. 2020;5:801–812
Publicado: (2020)

Corrigendum to Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy. Kidney Int Rep. 2021;6:91-100.
Publicado: (2021)

Hollinger A, Wittebole X, François B, et al. Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: the Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018;3:1424–1433
Publicado: (2018)

Mass Spectrometry-Based Lipidomics Reveals Differential Changes in the Accumulated Lipid Classes in Chronic Kidney Disease
por: Marczak, Lukasz, et al.
Publicado: (2021)

Ismail H, Abdul Manaf MR, Abdul Gafor AH, et al. Economic burden of ESRD to the Malaysian health care system. Kidney Int Rep. 2019;4:1261–1270
Publicado: (2019)

Health Tract, No. 268: Adulterations
Publicado: (1867)

Perrone RD, Mouksassi M-S, Romero K, et al. Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease. Kidney Int Rep. 2017;2:442–450
Publicado: (2018)

TnpA(REP) and REP sequences dissemination in bacterial genomes: REP recognition determinants
por: Corneloup, Alix, et al.
Publicado: (2021)

Imaging by photon counting with 256 x 256 pixel matrix
por: Tlustos, Lukas, et al.
Publicado: (2004)

Corrigendum to High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 [Translational Oncology Volume 12, Issue 2, February 2019, Pages 256-268]
por: Golob-Schwarzl, N., et al.
Publicado: (2020)

Meneghini M, Melilli E, Martorell J, et al. Combining sensitive crossmatch assays with donor/recipient human leukocyte antigen eplet matching predicts living-donor kidney transplant outcome. Kidney Int Rep. 2018;3:926–938
Publicado: (2019)

Corrigendum to “Morales-Alvarez MC, Garcia-Dolagaray G, Millan-Fierro A, Rosas SE. Renal function decline in Latinos with type 2 diabetes.” Kidney Int Rep. 2019;4:1230–1234
Publicado: (2020)

Insufficient early renal recovery and progression to subsequent chronic kidney disease in living kidney donors
por: Kim, Yaerim, et al.
Publicado: (2022)

Vitamin D insufficiency and deficiency in children with chronic kidney disease
por: Kari, Jameela Abdulaziz, et al.
Publicado: (2012)

Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease
por: Afshinnia, Farsad, et al.
Publicado: (2020)

Beyond the ABCs—Discovery of Three New Plasmid Types in Rhodobacterales (RepQ, RepY, RepW)
por: Freese, Heike M., et al.
Publicado: (2022)

Corrigendum to Ng MS, Malacova E, Hurst C, David MC, Johnson DW, Mallett AJ. “Clinical Outcomes of People With Fabry Disease — ANZDATA Registry Study.” Kidney Int Rep. 2021;6:2481–2485
por: Ng, Monica S., et al.
Publicado: (2022)

Corrigendum to Davies SJ, Zhao J, Morgenstern H, et al. Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS. Kidney Int Rep. 2021;6:313-324.
Publicado: (2021)

Immunizations in Chronic Kidney Disease and Kidney Transplantation
por: Babu, Tara M., et al.
Publicado: (2021)

Gluconeogenesis in the kidney: in health and in chronic kidney disease
por: Dalga, Delal, et al.
Publicado: (2023)

Kidney Lipidomics by Mass Spectrometry Imaging: A Focus on the Glomerulus
por: Abbas, Imane, et al.
Publicado: (2019)

Comprehensive Lipidome Profiling of the Kidney in Early-Stage Diabetic Nephropathy
por: Hou, Biyu, et al.
Publicado: (2020)

268 Nonuremic Calciphylaxis—A Rare Case
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_to1h4c6qbvmm16c0jtdu4l3hkr